Abstract. In the post-genomic era, the main aim of cancer research is organizing the large amount of data on gene expression and protein abundance into a meaningful biological context. Performing integrated analysis of genomic and proteomic data sets is a challenging task. To comprehensively assess the correlation between mRNA and protein expression, we focused on the gene set enrichment analysis, a recently described powerful analytical method. When the differentially expressed proteins in 12 colorectal cancer tissue samples were con sidered a collective set, they exhibited significant concordance with primary tumor gene expression data in 180 colorectal cancer tissue samples. We found that 53 upregulated proteins were significantly enriched in genes exhibiting elevated gene expression levels (P<0.001, ES=0.53), indicating a positive correlation between the proteomic and transcriptomic data. Similarly, 44 downregulated proteins were significantly enriched in genes exhibiting elevated gene expression levels (P<0.001, ES -0.65). Moreover, we applied gene set enrichment analysis to identify functional genetic pathways in CRC. A relatively large number of upregulated proteins were related to the two principal pathways; ECM receptor interaction was related to heparan sulfate proteoglycan 2 and vitronectin, and ribosome to RPL13, RPL27A, RPL4, RPS18, and RPS29. In conclusion, the integrated understanding of both genomic and proteomic data sets can lead to a better understanding of functional inference at the physiological level and potential molecular targets in clinical settings.
Introduction
The advent of genomic and proteomic technologies for the analysis of human tumor samples has now added an additional source of information to clinical cancer research (1) . Genomic technologies have enabled rapid and sensitive screening for global and specific changes in gene expression that occur in hundreds of samples (2) . Proteomic techniques based on massspectroscopy have enabled us to characterize and quantify thousands of proteins, which are closely related to the phenotype of an organism (3) . Several previous studies have individually analyzed proteomic and transcriptomic data. Understanding the relevance and consistency of each data set individually is difficult and time-consuming. A major task in the post-genomic era is organizing this large amount of data on gene expression and protein abundance into a meaningful biological context.
We previously reported individual studies of mRNA and protein expression profile using DNA microarray and proteomics in colorectal cancer (CRC) (4, 5) . We believe that these studies should be expanded into a global integrated analysis of mRNA and protein expression profiles. However, a major limitation is that a less than perfect correlation often exists between mRNA and protein expression (6, 7) . Variations between the mRNA level of a gene and its corresponding protein abundance can be as high as 30-fold (8) . Potential biological reasons for the lack of correlation between mRNA and protein expression levels are: i) translational regulation, ii) differences in protein in vivo half-lives, and iii) differences with respect to the experimental platforms (9, 10) . In addition, possible reasons for this poor correlation may include methodological constraints that might affect the comparison of mRNA and protein levels. Previous studies have reported that the Pearson correlation coefficient and Spearman rank coefficient for these data ranged from 0.47 to 0.76 in bacterial and mammalian cells (11) (12) (13) .
To comprehensively assess the correlation between mRNA and protein expression in CRC, in this study, we focused on a recently described powerful analytical method known as the gene set enrichment analysis (GSEA) (14) . GSEA determines Potential biological insights revealed by an integrated assessment of proteomic and transcriptomic data in human colorectal cancer ICHIRO (14) . We hypothesized that the GSEA approach, which was not controlled by different dynamic range, might be more suitable to evaluate the correlation between mRNA and protein levels than the traditional correlation coefficient analysis. Of note, GSEA revealed a relationship that had not been previously evaluated by traditional analysis. We sought to identify potential biological regulatory pathways in humans in large sample size (180 CRCs data) using this GSEA application that is also known as the global analytical approach to evaluate regulatory gene sets associated with several biological mechanisms of cancer. We examined the relevance of these pathways in transcriptomic and proteomic analysis of upregulated proteins. Of note, several upregulated proteins have been found to be associated with genomic pathways playing an important role in carcino genesis. In conclusion, the integrated analysis of genomic and proteomic data sets can lead to a better understanding of functional inference at the physiological level and of potential molecular targets in clinical settings through identification of pathways and molecular subnetworks that are implicated in human CRC tissues.
Materials and methods
Tissue samples. CRC tissues and their adjacent normal colonic mucosal tissue counterparts used for 2-nitrobenzenesulfenyl (NBS) labeling were collected from 12 CRC patients who underwent surgical resection at Osaka University Hospital from 2003 to 2004 (clinicopathological features are described in Table I ). For DNA microarray, samples of 180 CRC tissues and 40 normal colonic mucosal tissues were obtained from patients who underwent surgical resection at Osaka University Hospital from 2003 to 2006. After surgical resection, tissues were immediately stored at -80˚C prior to analysis. None of the patients received chemotherapy or radiotherapy before surgery. Necrotic tissue was excluded from the study and none of the adenomas contained a cancerous component. All normal tissues were histopathologically confirmed as cancer-free. All patients gave written informed consent; this study was approved by the Institutional Review Board for human tissue use at the Graduate School of Medicine, Osaka University.
Protein separation. Frozen tissue samples were homogenized in 500 ml of lysis buffer A (50 mM Tris-HCl at pH 8.0, 100 mM NaCl, 5 mM EDTA, 1 mM PMSF, 1 mg/ml leupeptin, and 5 mg/ml aprotinin) on ice using a Sample Grinding kit (GE Healthcare, Buckinghamshire, UK). Homogenates were centrifuged at 100,000 x g for 60 min and supernatants were collected as the cytosolic fraction (CF). Pellets were washed twice with lysis buffer A and homogenized in 500 ml of lysis buffer B (2% CHAPS, 9 M urea, 50 mM Tris-HCl at pH 8.0, 100 mM NaCl, 5 mM EDTA, 1 mM PMSF, 1 mg/ml leupeptin, and 5 mg/ml aprotinin); homogenates were centrifuged at 100,000 x g for 60 min. Supernatants were collected as 2% CHAPS-soluble fraction (CSF). These fractionated samples were precipitated using the 2D-Clean-Up kit (Bio-Rad, Hercules, CA) and resuspended in 8 M urea and 5 mM EDTA. After centrifugation at 100,000 x g for 5 min, supernatants were collected and subjected to NBS reagent labeling. Protein concentration was determined using the BCA Protein Assay kit (Pierce, Rockford, IL) using BSA as a standard.
NBS reagent labeling, peptide fractionation, and MS measurement. NBS reagent labeling was performed according to the manufacturer's protocol ( 13 CNBS stable isotope labeling kit-N; Shimadzu Biotech, Kyoto, Japan). Normal and tumor tissue samples (100 mg each) were labeled with isotopically light and heavy NBS reagents, respectively. NBS-labeled samples were then mixed, reduced, alkylated, and digested by trypsin. NBS-labeled peptides were enriched from tryptic digests and fractionated using Phenyl-Sepharose, as previously described (15) . The resulting seven fractions were combined into three fractions and subjected to reversed-phase liquid chroma tography (LC-10ADvp mHPLC system; Shimadzu), as previously described (16) . Eluates were automatically deposited onto MALDI target plates by the LC spotting system (AccuSpot; Shimadzu). These samples were automatically analyzed by MALDI-TOF MS (AXIMA-CFR Plus; Shimadzu/Kratos, Manchester, UK) (16). Gene expression profiling. Total RNA was purified from 180 CRC tissue samples using TRIzol reagent (Invitrogen, San Diego, CA), as previously described (17) . Integrity of the RNA was assessed on the Agilent 2100 Bioanalyzer and RNA 6000 LabChip kits (Yokokawa Analytical Systems, Tokyo, Japan). Only high quality RNA with intact 18s and 28s RNA were used for subsequent analysis. Forty RNA extractions from different normal colonic mucosal tissues were mixed and used as control reference. Extracted RNA samples were amplified with T7 RNA polymerase using the Amino Allyl MessageAmp™ aRNA kit (Ambion, Austin, TX) according to the manufacturer's protocol. The quality of each Amino Allyl-aRNA sample was checked on the Agilent 2100 Bioanalyzer. Control and experimental aRNA samples (5 µg) were labeled with Cy3 and Cy5, respectively; these samples were then mixed, and hybridized on an oligonucleotide microarray covering 30,336 human probes (AceGene Human 30K; DNA Chip Research Inc. and Hitachi Software Engineering Co., Yokohama, Japan). Experimental protocol is available at http://www.dna-chip.co.jp/thesis/AceGeneProtocol.pdf. The microarrays were scanned on the ScanArray 4000 (GSI Lumonics, Billerica, MA). Signal values were calculated using the DNASIS Array Software (Hitachi Software Inc., Tokyo, Japan). Following background subtraction, data with low signal intensities were excluded from additional investigation. In each sample, the Cy5/Cy3 ratio values were log-transformed. Then, global equalization to remove a deviation of the signal intensity between whole Cy3-and Cy5-fluorescence was performed by subtracting the median of all log (Cy5/Cy3) values from each log (Cy5/Cy3) value. Genes with missing values in >20% samples were excluded from further analysis; 24,537 genes out of 30,336 were analyzed.
Statistical integration of proteomics and transcriptomics.
To investigate the correlation between mRNA and protein levels for a set of differentially expressed proteins, we used the Spearman rank coefficient and GSEA, a computational method that determines whether an a priori defined set of genes shows statistically significant and concordant differences between two biological states, as previously reported (14) . In brief, using the gene expression profiles of the 180 CRC samples, the gene list L was ranked by calculating the mean expression level of each gene across all CRC samples. The differentially expressed proteins selected by NBS method were then mapped to their corresponding mRNAs and used as a test group set S against the ranked gene list L in GSEA analysis. Enrichment score (ES) of a test group set S characterizes whether the set S is randomly distributed across the list or falls mainly at the bottom or top of the list L. The null hypothesis that a test group set S randomly distributes across the ranked gene list L was tested with the Kolmogorov-Smirnov test, and the statistical significance value (nominal P-value) was estimated by 1000 random permutations of the phenotype labels. In this study, the test group set (differentially expressed proteins set) with a P<0.05 of ES was considered to be statistically significant correlation between mRNA and protein expression.
Assessment of significantly regulated pathways in CRC.
KEGG database (http://www.genome.jp/kegg/pathway.html) and GSEA 2.0.1 (a publicly available desktop application from the Broad Institute (http://www.broad.mit.edu/gsea/software/ software_index.html) (14) were employed to assess significantly regulated pathways in the 180 CRC gene expression data sets. In KEGG database, a test set size filter (min=15, max=500) was applied to 200 pathways. The enrichment score (ES) of a test set S and statistical significance value (nominal P-value) were estimated by permutations of the phenotype labels as described above. Test sets with a high significance (P<0.05) of ES were considered as potentially regulated pathways. We normalized the ES for each gene set to account for the size of the set, yielding a normalized enrichment score (NES). We then control the proportion of false positives by calculating the false discovery rate (FDR) (18) corresponding to each NES. FDR is the estimated probability that a set with a given NES represents a false positive finding; it is calculated by comparing the tails of observed and null distributions for NES.
Results
Proteomic profiling and identification of differentially expressed proteins in 12 CRC tissues. The NBS method was used for profiling protein expression in a set of tumor and normal tissue samples from 12 CRC patients. After a series of experiments, ~2,600-3,000 peak pairs were observed in each analysis. After relative quantification of each peak pair in each sample, 320 pairs were found to have significant alterations in protein expression and occurred with significant frequency in patients. After these peaks were subjected to MS/MS analysis, 226 MS/MS spectra were obtained, and 156 search results were considered as positive identifications. In total, 128 proteins were confirmed as CRC-associated proteins. Of these, 71 proteins were upregulated and 57 proteins were downregulated in tumor tissue compared to those in normal tissue in CF and CSF analyses, respectively. Using UniPlot Protein database (http:// www.uniprot.org/) and matching Entrez Gene ID, we mapped these differentially expressed proteins to their corresponding mRNA counterparts. Finally, we focused on 53 upregulated and 44 downregulated proteins, for which mRNA expression was determined by cDNA microarray analysis (Tables II and III) . Spearman rank coefficient between mRNA and protein expression in CRC. Fig. 1 illustrates our experimental design for correlation analysis. We initially investigated the extent to which expression data at the protein and mRNA levels were correlated in CRC using traditional correlation coefficient approach. The identified differentially expressed proteins, the expression ratios for these upregulated and down-regulated proteins, and the expression ratios for each corresponding mRNA transcript are provided in Tables II and III . Fig. 2A and B show the expression ratios of uniquely identified proteins plotted against ratios of the products of the corresponding genes at the mRNA level. A nonparametric correlation analysis of the experimental data using Spearman rank correlation method gave a correlation coefficient of 0.36 for up-regulated proteins data, and a correlation coefficient of 0.28 for down-regulated proteins data. This indicates a poor correlation between mRNA and protein expression ratios.
Evaluation of the correlation between mRNA and protein expression using GSEA. Next, we integrated proteomic data and global transcriptomic data to examine the correlation between mRNA and protein levels using GSEA approach. We focused on the 53 up-regulated and 44 down-regulated proteins shown in Tables II and III . To map these differentially expressed proteins to their corresponding mRNA counterparts, we used the Entrez Gene ID and UniPlot Protein database (http://www. uniprot.org/). Then, 24,537 genes after processing were ranked according to their magnitude of differential gene expression in 180 CRC tissues, obtained by microarray and analyzed using GSEA to examine the distribution of the 53 up-regulated proteins. We found that the 53 up-regulated proteins were significantly enriched in genes exhibiting elevated gene expression levels (P<0.001, ES=0.53), indicating a positive correlation between proteomic and transcriptomic data (Fig. 3A) . Similarly, the 44 down-regulated proteins were significantly enriched in genes exhibiting elevated gene expression levels (P<0.001, ES -0.65), indicating a positive correlation between proteomic and transcriptomic data (Fig. 3B) .
Identification of characteristic genomic pathways and potential regulatory proteins associated with CRC tissues.
After defining the differentially expressed proteins in 180 CRC tissues, the challenge was to objectively interpret potential biological mechanisms. We performed GSEA to identify functional genetic pathways (KEGG database; http://www. genome.jp/kegg/pathway.html) that correlate with the entire ranked gene list from 180 CRC tissues, sorted by their magnitude of differential gene expression. Of the 200 gene sets that contained genes whose products were involved in specific metabolic and signaling pathways, 12 were significantly enriched with nominal P<0.05, as shown in Table IV . Among the molecules within these 12 pathways in KEGG database, we found several up-regulated proteins obtained by NBS analysis. In particular, a relatively large number of up-regulated proteins were related to the principal two pathways; ECM receptor interaction was related to HSPG2 and VTN, and ribosome to RPL13, RPL27A, RPL4, RPS18, and RPS29. Figure 1 . The schematic of our experimental design for correlation analysis. From NBS-based proteomics using 12 CRC tissues, expression data of 53 up-regulated and 44 down-regulated proteins were obtained. From DNA microarray using 180 CRC tissues, 24,536 gene expression profiles were obtained. We investigated the correlation between mRNA and protein levels for a set of differentially expressed proteins, using the Spearman rank coefficient and GSEA. 
Discussion
The recent availability of platform technologies for high throughput transcriptomics and proteomics has led to integrated approaches to cancer research. Integrated analysis of global scale transcriptomics and proteomics data can provide important insights into the biological mechanisms underlying complex physiological processes (19) . However, it is difficult to accurately evaluate their correlation using the conventional correlation coefficient analysis, which deals with a fold change (20) . Regulatory proteins and sRNAs also act as translational modulators (21). The half-live of an individual protein and the protein turnover are undoubtedly influencing the correlation between mRNA and protein expression to a considerable degree (22) . In this study, we assumed that development of a sophisticated statistical approach was essential to overcome these limitations. To assess the correlation between mRNA and protein expression, we tried the novel approach of GSEA that deals with entire genes represented by an array as ranked gene list ordered by phenotypic correlation (14, 23) . As expected, the conventional Spearman rank coefficient showed only a weak correlation. In GSEA, when differentially expressed proteins were treated as a collective set, significant concordance was observed with primary tumor gene expression data.
In the present study, NBS method also plays a role in improving the precision of correlation analysis. This method is based on stable isotope labeling of tryptophan residues by NBS reagents. As previously described (15, 24) , this novel method has two major advantages: it reduces the number of peptides by selecting NBS-labeled tryptophan-containing peptides from bulk tryptic digests and a special matrix is used for MALDI-TOF MS measurements that can detect NBS-labeled peptides with high sensitivity. Therefore, this method could improve proteome mining by increasing the dynamic range of detection, and it shows potential for quantitative proteome analysis (25, 26) .
As a following step, GSEA enabled us to identify 12 potentially regulated genetic pathways in CRC. Cell-ECM (extracellular matrix) interaction is an essential mechanism in several biological processes, such as cell proliferation, migration, differentiation, apoptosis, as well as carcinogenesis (27, 28) . CRC cells invade the stroma as coherent cell nests instead of single cells (29, 30) . Of the molecules within ECM interaction pathway, HSPG2 and VTN were revealed as potential key modulators by NBS-based proteomics. HSPG2, the large prominent heparan sulfate proteoglycan of extracellular matrices, is known as a component that may participate in ECM interaction (31) . Within the matrix, vitronectin can support cellular adhesion through interactions with integrins (32) . In addition, vitronectin is a major component of the stroma of primary hepatocellular carcinoma and metastatic hepatic tumors including colorectal hepatic metastases (32, 33) .
The ribosome pathway is essential for protein synthesis. The increased overall ribosome biogenesis is a well-known common feature of active proliferation, and the proliferation rate of tumor cells is higher than that of normal ones (34) . Ribosomal proteins (RPs) showed different expression patterns: not all RPs increased in the same tumor or tissue, and the same RP was expressed differentially in different tumors or different stages of diseases (35) . In our study, of the molecules within Ribosomal proteins, RPL13, RPL27A, RPL4, RPS18, and RPS29 were up-regulated at the protein level. Previous studies on CRC revealed extraribosomal functions for these proteins including self-translation regulation, development regulation, and tumor suppressor gene regulation (36, 37) .
The assumption of GSEA is that functional gene sets with significantly high expression coherence suggest putative functionality. It must be noted that annotated functions of gene sets with higher expression coherence do not always directly correspond with the actual biological functions (38) . Nonetheless, several physiological cellular responses require simultaneous participation of gene products, and genes with central roles are likely to have similar regulatory control and expression patterns (39, 40) . Comparative analysis also showed that coexpression patterns of many functionally related genes are conserved across diverse species (41) . Thus, most gene sets with significantly high expression coherence, if not all, might represent key molecular functions of the corresponding expression profiles.
In conclusion, we performed an integrated analysis of mRNA and protein expression data in CRC. Overall, significant correlation was observed between changes in mRNA and protein levels that were consistent with the expectation that a substantial proportion of changes in protein would be a consequence of changes in mRNA levels rather than post-transcriptional effects. Our identified regulatory signatures of mRNA and protein levels might be able to enhance the understanding of carcinogenesis and cancer proliferation and lead to the elucidation of novel molecular targets in the clinical field.
